Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01818297 · ClinicalTrials.gov registry record · NA
Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT01818297 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 137 participants.
The verdict
NCT01818297, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of Subcutaneous Nerve Stimulation (SQS) (also known as Peripheral Nerve Stimulation \[PNS\]) in the reduction of chronic, intractable post-surgical back pain in adults.
Interventions
- DEVICE PrimeAdvanced® neurostimulator system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2013-04 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01818297
The ClinicalTrials.gov registry entry for NCT01818297 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PrimeAdvanced® neurostimulator system is the first listed.
NCT01818297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01818297 about?
NCT01818297 is a clinical study titled "Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients". The purpose of this study is to assess the safety and efficacy of Subcutaneous Nerve Stimulation (SQS) (also known as Peripheral Nerve Stimulation \[PNS\]) in the reduction of chronic, intractable post-surgical back pain in adults.
What is the current status of trial NCT01818297?
This trial is currently terminated. It is a NA study. The enrollment target is 137 participants. The study started on 2013-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01818297?
The interventions under investigation include: PrimeAdvanced® neurostimulator system (DEVICE).
Who is sponsoring clinical trial NCT01818297?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.